Gerst Diane G. 4
4 · Amphastar Pharmaceuticals, Inc. · Filed Jul 5, 2022
Insider Transaction Report
Form 4
Gerst Diane G.
Corp. SVP of Quality Assurance
Transactions
- Exercise/Conversion
Common Stock
2022-06-30$20.03/sh+3,333$66,760→ 16,175 total - Exercise/Conversion
Common Stock
2022-06-30$20.08/sh+1,813$36,405→ 17,988 total - Exercise/Conversion
Stock Option (right to buy)
2022-06-30−1,813→ 6,190 totalExercise: $20.08Exp: 2028-06-08→ Common Stock (1,813 underlying) - Exercise/Conversion
Stock Option (right to buy)
2022-06-30−3,333→ 3,626 totalExercise: $20.03Exp: 2027-06-12→ Common Stock (3,333 underlying) - Sale
Common Stock
2022-06-30$35.00/sh−5,146$180,110→ 12,842 total
Footnotes (2)
- [F1]The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 13, 2022.
- [F2]Shares subject to the option are fully vested and immediately exercisable.